|
Status |
Public on Aug 17, 2024 |
Title |
The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
Web link |
https://www.biorxiv.org/content/10.1101/2024.08.17.607802v1
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Aug 16, 2024 |
Last update date |
Aug 19, 2024 |
Contact name |
Robert Fisher |
E-mail(s) |
rjfisher@bu.edu
|
Organization name |
Boston University
|
Department |
Dermatology
|
Lab |
Alani
|
Street address |
609 Albany St
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02118 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (22)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE275047 |
The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors (ATAC-Seq) |
GSE275048 |
The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors (RNA-Seq) |
|
Relations |
BioProject |
PRJNA1149008 |